PC
PointState Capital Portfolio holdings
AUM
$4.67B
This Quarter Return
+5.9%
1 Year Return
+24.63%
3 Year Return
+80.28%
5 Year Return
+158.5%
10 Year Return
+665.76%
AUM
$2.75B
AUM Growth
+$2.75B
(-15%)
Cap. Flow
-$335M
Cap. Flow
% of AUM
-12.18%
Top 10 Holdings %
Top 10 Hldgs %
61.63%
Holding
141
New
36
Increased
8
Reduced
12
Closed
69
Top Buys
| 1 |
Microsoft
MSFT
|
$311M |
| 2 |
EQT Corp
EQT
|
$164M |
| 3 |
Antero Resources
AR
|
$127M |
| 4 |
T-Mobile US
TMUS
|
$109M |
| 5 |
Shell
SHEL
|
$99.7M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$223M |
| 2 |
Palo Alto Networks
PANW
|
$217M |
| 3 |
Booking.com
BKNG
|
$201M |
| 4 |
D.R. Horton
DHI
|
$173M |
| 5 |
Workday
WDAY
|
$142M |
Sector Composition
| 1 | Energy | 35.54% |
| 2 | Technology | 34.1% |
| 3 | Industrials | 9.14% |
| 4 | Communication Services | 8.71% |
| 5 | Materials | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alnylam Pharmaceuticals
ALNY
$58.5B
| – | – |
-30,000
| Closed | -$5.09M |
|
77
Altimmune
ALT
$338M
| – | – |
-135,000
| Closed | -$1.24M |
|
78
Ardagh Metal Packaging
AMBP
$2.21B
| – | – |
-2,715,725
| Closed | -$24.5M |
|
|
AMED
79
DELISTED
Amedisys
AMED
| – | – |
-15,000
| Closed | -$2.43M |
|
80
argenx
ARGX
$43.6B
| – | – |
-10,200
| Closed | -$3.57M |
|
81
ARK Innovation ETF
ARKK
$7.45B
| – | – |
0
| – | – |
|
82
Algoma Steel
ASTL
$511M
| – | – |
-850,718
| Closed | -$9.2M |
|
83
Avantor
AVTR
$9.18B
| – | – |
-240,000
| Closed | -$10.1M |
|
84
AstraZeneca
AZN
$248B
| – | – |
0
| – | – |
|
85
Biogen
BIIB
$19.4B
| – | – |
-21,000
| Closed | -$5.04M |
|
|
86
Booking.com
BKNG
$181B
| – | – |
-83,625
| Closed | -$201M |
|
87
Bristol-Myers Squibb
BMY
$96B
| – | – |
-77,500
| Closed | -$4.83M |
|
88
BioNTech
BNTX
$24B
| – | – |
-3,908
| Closed | -$1.01M |
|
89
Boston Scientific
BSX
$156B
| – | – |
-151,000
| Closed | -$6.41M |
|
90
CF Industries
CF
$14B
| – | – |
-49,495
| Closed | -$3.5M |
|
91
Centene
CNC
$14.3B
| – | – |
-155,000
| Closed | -$12.8M |
|
92
CVS Health
CVS
$92.8B
| – | – |
-172,500
| Closed | -$17.8M |
|
|
93
D.R. Horton
DHI
$50.5B
| – | – |
-1,593,008
| Closed | -$173M |
|
94
Eventbrite
EB
$256M
| – | – |
-480,539
| Closed | -$8.38M |
|
95
iShares MSCI Emerging Markets ETF
EEM
$19B
| – | – |
0
| – | – |
|
96
Elanco Animal Health
ELAN
$9.12B
| – | – |
-200,000
| Closed | -$5.68M |
|
97
Enovis
ENOV
$1.77B
| – | – |
-220,000
| Closed | -$10.1M |
|
98
Enanta Pharmaceuticals
ENTA
$180M
| – | – |
-13,500
| Closed | -$1.01M |
|
99
Gilead Sciences
GILD
$140B
| – | – |
0
| – | – |
|
100
GSK
GSK
$79.9B
| – | – |
-110,000
| Closed | -$4.85M |
|